Investors & Media

Corporate Profile

Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.

 


Recent Financial Filings

Filing date Form Filing Group
UPLOAD
Other
UPLOAD
Other
UPLOAD
Other

Stock Information

AURA BIOSCIENCES


February 5, 2023 9:01 AM EST
Data Provided by Refinitiv. Minimum 15 minutes delayed.